MARKET

XAIR

XAIR

Beyond Air Inc
NASDAQ
7.23
+0.49
+7.27%
After Hours: 7.16 -0.07 -0.97% 17:31 02/03 EST
OPEN
6.63
PREV CLOSE
6.74
HIGH
7.25
LOW
6.63
VOLUME
440.17K
TURNOVER
0
52 WEEK HIGH
11.76
52 WEEK LOW
4.785
MARKET CAP
217.10M
P/E (TTM)
-4.1845
1D
5D
1M
3M
1Y
5Y
Beyond Cancer appoints Gavin Choy as COO
Seeking Alpha · 4d ago
You Ask, We Analyze: UNO Innovator Beyond Air Shows Strength Compared To General Market
Benzinga · 01/25 16:51
BRIEF-Beyond Cancer® Announces Sponsored Research Agreement With Stanford
Reuters · 01/24 22:27
Beyond Cancer Announces Sponsored Research Agreement With Stanford And Appointment Of Frederick M. Dirbas, MD And Mark D. Pegram, MD To Scientific Advisory Board
Benzinga · 01/24 21:14
Beyond Cancer Publishes Pre-Clinical Data In Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide Induced A Systemic Response that Prevents Metastases
Benzinga · 12/13/2022 14:26
Over $16 Million Bet On AMERCO? Check Out These 3 Stocks Insiders Are Buying
Benzinga · 12/12/2022 11:35
Insider Buy: Beyond Air
Insider Buy: Beyond Air
MT Newswires · 12/09/2022 16:25
Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session
Benzinga · 11/21/2022 18:36
More
About XAIR
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Company’s LungFit platform can be used to treat patients on ventilators that require NO, as well as patients with chronic or acute severe lung infections through delivery through a breathing mask or similar apparatus. The Company’s areas of focus with LungFit are Persistent Pulmonary Hypertension of the Newborn (PPHN), community-acquired viral pneumonia (CAVP), including COVID-19, bronchiolitis (BRO), nontuberculous mycobacteria (NTM) lung infection and with various severe lung infections with underlying chronic obstructive pulmonary disease (COPD). Its LungFit PH is an ionizer technology to generate on-demand nitric oxide from ambient air and, regardless of dose or flow, deliver it to a ventilator circuit.

Webull offers kinds of Beyond Air Inc stock information, including NASDAQ:XAIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XAIR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XAIR stock methods without spending real money on the virtual paper trading platform.